As the roles of specific genes and their functions in cancer etiology and p
rogression become defined, the necessity of looking at multiple genes and t
heir interaction becomes clearer, In gastrointestinal cancer, tumor suppres
sor and promoter genes, cell cycle control and angiogenic factors, repair g
enes, and metabolic genes have been examined as they relate to prognosis an
d therapeutic outcomes. To date, most correlative studies for specific mole
cular parameters have been done retrospectively. Methodologies, sample size
s, and definitions differ. The following analysis provides a brief review o
f the current state of knowledge and recent research on the most commonly s
tudied molecular markers, and the newer areas of inquiry attempting to defi
ne how to use molecular-genetic features of individual tumors as targets fo
r more effective therapies. Consideration is given to the design of trials
employing molecular targets as outcome factors. (C) 2001 Lippincott William
s & Wilkins, Inc.